Tokyo, Japan

Tomonori Fujioka


 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tomonori Fujioka: Innovator in Cyclic Peptide Synthesis

Introduction

Tomonori Fujioka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cyclic peptide synthesis, holding a total of 4 patents. His work focuses on identifying gene clusters involved in the biosynthesis of cyclic peptide compounds produced by filamentous fungi.

Latest Patents

Fujioka's latest patents include groundbreaking inventions such as a gene involved in the synthesis of cyclic peptide compounds and a method for producing these compounds. His research aims to establish a system for synthesizing cyclic peptide compounds by identifying a gene cluster that encodes proteins responsible for synthesizing nonribosomal peptides. Additionally, he has developed a method for producing dihydrotentoxin, which involves identifying enzymes that synthesize dihydrotentoxin and tentoxin, further advancing the understanding of tentoxin synthesis-related genes.

Career Highlights

Throughout his career, Tomonori Fujioka has worked with notable organizations, including Kumiai Chemical Industry Co., Ltd. and Tohoku University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to significant advancements in peptide synthesis.

Collaborations

Fujioka has collaborated with esteemed colleagues such as Takashi Kubo and Masayuki Machida. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Tomonori Fujioka's contributions to cyclic peptide synthesis and his innovative patents highlight his role as a leading inventor in the field. His work continues to influence research and development in peptide synthesis, showcasing the importance of collaboration and innovation in scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…